Wafra Inc. Johnson & Johnson Transaction History

Wafra Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $28.8 Million - $32.1 Million	178,596 Added 497.45%	214,498 $35 Million
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $48,775 - $53,942	290 Added 0.81%	35,902 $6.37 Million
Q1 2022 May 16, 2022	BUY	$158.14 - $179.59 $5.63 Million - $6.4 Million	35,612 New	35,612 $6.31 Million
Q2 2018 Aug 09, 2018	SELL	$119.4 - $131.76 $24.9 Million - $27.4 Million	-208,332 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $337,235 - $369,103	2,570 Added 1.25%	208,332 $29.1 Million
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $26.6 Million - $27.9 Million	205,762	205,762 $26.8 Million

4,275

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Wafra Inc., based on Form 13F filings with the SEC.

Stay updated on Wafra Inc. with notifications on news.